Previous 10 | Next 10 |
2024-05-29 18:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
A look at the top 10 most actives in the United States Pineapple Energy Inc. (PEGY) rose 46.0% to $0.2601 on volume of 655,453,952 shares Sharps Technology Inc. (STSS) rose 141.4% to $0.5174 on volume of 299,690,189 shares Greenwave Technology Solutions Inc. (GWAV) fell 7.4% to $0.0786 on...
2024-05-28 16:00:06 ET Maury Raycroft from Jefferies issued a price target of $39.00 for CALT on 2024-05-28 13:15:00. The adjusted price target was set to $39.00. At the time of the announcement, CALT was trading at $37.955. The overall price target consensus is at $49.0...
2024-05-28 15:30:03 ET Jefferies analyst issues HOLD recommendation for CALT on May 28, 2024 01:23PM ET. The previous analyst recommendation was Buy. CALT was trading at $37.95 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current anal...
2024-05-28 14:04:21 ET More on Mid-day movers & stock Semler Scientific: Great Product Can Still Thrive Post Medicare Advantage Semler Scientific, Inc. (SMLR) Q1 2024 Earnings Call Transcript G1 Therapeutics, Inc. (GTHX) Q1 2024 Earnings Call Transcript A...
2024-05-28 13:35:36 ET More on Travere Therapeutics Travere Therapeutics, Inc. (TVTX) Q1 2024 Earnings Call Transcript Travere Therapeutics Q1 2024 Earnings Preview Travere, CSL win conditional nod for kidney disease therapy in EU Seeking Alpha’s Quant...
2024-05-28 10:20:20 ET Summary Asahi Kasei will acquire Calliditas Therapeutics AB (publ) for $1.1 billion, representing an 83% premium to the closing price on the Stockholm exchange and a 74% premium to the Nasdaq closing price. The primary asset of interest in the acquisition is...
2024-05-28 10:00:33 ET More on Health Care Select Sector SPDR XLV: Healthcare Is Ripe For Buying, Despite Patent Cliff XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care Short interest in S&P 500 ...
A look at the top 10 most actives in the United States Pineapple Energy Inc. (PEGY) rose 121.3% to $0.3941 on volume of 248,629,940 shares Sharps Technology Inc. (STSS) rose 184.6% to $0.61 on volume of 114,390,080 shares Crown Electrokinetics Corp. (CRKN) rose 31.2% to $0.1325 on volume ...
Calliditas Therapeutics Presents Data at the 61st European Renal Association Congress PR Newswire STOCKHOLM , May 28, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ("Calliditas"), today announced the presentations ...
News, Short Squeeze, Breakout and More Instantly...
Calliditas Therapeutics AB Company Name:
CALT Stock Symbol:
NASDAQ Market:
Launch of Phase 3 clinical trial with Nefecon in Japan PR Newswire STOCKHOLM , July 4, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatri...
2024-06-30 09:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Calliditas provides setanaxib patent update PR Newswire STOCKHOLM , June 18, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ("Calliditas") today announced that the United States Patent and Trademark Office (USPTO) h...